A federal judge in Texas threw out a Biden-era rule last week that would have ramped up federal audits of private Medicare ...
Study finds 99% of all heart attacks, heart failure, or strokes occur in people with "suboptimal" blood pressure, cholesterol ...
GSK announced that Luke Miels, the company’s chief commercial officer, will take over as CEO on Jan. 1, replacing Emma ...
In today's Morning Rounds newsletter, burning questions on MMR vaccines, a perimenopause business boom, and more.
Lisa Suennen: "If this is going to make it a lot more expensive to get the same outcome, that is not a good investment." ...
The Danish company Genmab plans to buy Merus, the maker of a promising head and neck cancer drug, in a deal worth roughly $8 ...
Francer is Lilly’s vice president, head of global regulatory policy and strategy. Cruz is Lilly’s senior vice president, ...
Insurance companies continue to innovate. On Oct. 1, Cigna will roll out a policy that tracks how physicians bill. It will ...
The more we talk, debate, even sometimes argue, the more we can live well with a mind altered by these progressive, disabling ...
Perimenopause brings real symptoms and a booming market of supplements, apps, and therapies. What’s hype, what’s helpful, and ...
MoonLake Immunotherapeutics tried hard to spin the poor results of its candidate for an autoimmune skin condition.
GSK CEO Emma Walmsley is stepping down next year after leading the company since 2017, aiming to pivot the U.K. firm into an innovative pharma company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback